CEN Biotech, Inc. CENBF

Company Overview

CEN Biotech, Inc. was a Canadian company associated with the medical cannabis sector and was publicly quoted in the United States under the ticker symbol CENBF on the OTC market. Public disclosures and historical corporate materials indicate that the company sought to develop large-scale cannabis cultivation and production facilities in Canada during the early expansion of the country’s regulated medical marijuana industry. The company’s proposed business model focused on cultivating and distributing medical cannabis under Canada’s federal licensing framework in effect at the time.

Historical records indicate that CEN Biotech positioned itself as a high-capacity greenhouse cannabis producer targeting the emerging medical marijuana market in Canada. The company’s strategy emphasized controlled-environment cultivation facilities and projected production scale as competitive differentiators. Publicly available information also shows that the company attracted investor attention during the early commercialization phase of the North American cannabis industry. However, multiple public sources indicate that regulatory approvals and licensing outcomes became a major challenge for the business, and reliable recent operational disclosures are limited. Data regarding current active operations is inconclusive based on available public sources.